Grifols (0RDU)
Grifols (GRF) is a global healthcare company based in Spain, specializing in the development, production, and marketing of plasma-derived medicines. It operates primarily in the biopharmaceutical sector, focusing on therapies for rare and chronic diseases. Grifols' core products include immunoglobulins, albumin, and clotting factors derived from human plasma, which are essential for treating conditions such as immune deficiencies, hemophilia, and liver diseases. The company is also involved in the hospital and diagnostic sectors, providing a range of products and services that support healthcare professionals and patients.